Arrhythmias & electrophysiology

Subcutaneous Implantable Cardioverter-Defibrillator: A Systematic Review of Comparative Effectiveness and Safety

ESC Heart FailPublished Systematic review of randomised and controlled observational studies

Pooled result · Inappropriate shocks and device-related complications (RCT)Result — go to the resultHazard ratio 0.99 95% CI 0.71–1.39

Authors' conclusion

The available evidence is insufficient to show the superiority of S-ICD compared with TV-ICD, hindering the widespread use of the technology.

Study context

Population
Patients at increased risk of SCD with an ICD indication for primary or secondary prevention1 RCT (n = 849) + 4 observational (n = 7149)
Comparison
S-ICD vs TV-ICD
Outcome
Primary composite endpoint of the RCT
Follow-up
4 years
Methodological detailsGrading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence grading, Evidence graded low to very low, except moderate for the RCT primary composite endpoint
  • GRADE evidence grading
  • Evidence graded low to very low, except moderate for the RCT primary composite endpoint

Pooled result

As reported in the abstract

Inappropriate shocks and device-related complications (RCT)

Hazard ratio

0.99

95% CI 0.71–1.39

P = 0.001

Events by group

S-ICDvs TV-ICD
HR 0.99 (95% CI 0.71–1.39); P = 0.001

Further pooled results

OutcomeS-ICDTV-ICDHR (95% CI)P value
Appropriate shocks (RCT)19.2%11.5%1.52 (1.08–2.12)P = 0.02
OutcomeS-ICDTV-ICDP value
Appropriate shocks (one observational study)9.9% (95% CI 7.0–13.9)13.9% (95% CI 10.8–17.8)P = 0.003

Overall mortality and shock efficacy

No significant difference in any included study
P > 0.05

Safety

OutcomeS-ICDTV-ICDHR (95% CI)
Lead complications (RCT) · 4 years1.4%6.6%0.24 (0.10–0.54)

Lead complications (observational study) · 3 years

P = 0.03

Lead complications (observational study) · 5 years

P = 0.03

Inappropriate shocks (one observational study)

P = 0.007

Inappropriate shocks (one observational study) — RCT and two other observational studies: no significant difference
P > 0.05

Original publication

Subcutaneous Implantable Cardioverter-Defibrillator: A Systematic Review of Comparative Effectiveness and Safety. ESC Heart Fail. Published 29 November 2022. doi:10.1002/ehf2.14249

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.